One additional TCGA cohort, bladder urothelial carcinoma, showed a significant association between FOXP1-SHQ1 deletion and PIK3CA mutation or amplification (Supplementary Table 2). The gene discussed is FOXP1; the disease is bladder transitional cell carcinoma.